BETi-211

BETi-211 is an orally active BET inhibitor (Ki: 50 [1].

Product Specifications

CAS Number

[1995867-02-1]

UNSPSC

12352005

Target

Epigenetic Reader Domain

Type

Reference compound

Related Pathways

Epigenetics

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/beti-211.html

Smiles

COCC1=NC(NC2=CC(C3CC3)=NN2CC)=C4C(NC5=C4C=C(OC)C(C6=C(C)ON=C6C)=C5)=N1

Molecular Formula

C26H29N7O3

Molecular Weight

487.55

References & Citations

[1]Bai L, et al. Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. Cancer Res. 2017 May 1;77 (9) :2476-2487.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-06355AF532 0.1 mL

Rabbit Polyclonal PRR12 Antibody [Alexa Fluor 532]

Ask

View Details

21510879-2 2 mg

Styphnolobium japonicum Lectin (SJA) - Biotinylated

Ask

View Details

QP10309-ec-10ug 10ug

Recombinant Human IL2/ Interleukin-2 Protein, Untagged, E.coli-10ug

Ask

View Details

A63697-50UG 50 µg

RTP4 Antibody

Ask

View Details

BT-AP10766-01 20 µL

Ku-70 (Acetyl Lys317) Polyclonal Antibody

Ask

View Details

BT-AP10766-02 50 µL

Ku-70 (Acetyl Lys317) Polyclonal Antibody

Ask

View Details